Qiming Stars | Three CEOs of Qiming Venture Partners Portfolio Companies Named 2025 AI Figures of the Year
Awards showcase the latest practices, fruitful achievements, and broad prospects of China's AI sector.
During the 2025 World Artificial Intelligence Conference (WAIC), the large-scale themed event on AI industry development hosted by China Media Group — "2025 China · AI Ceremony" — kicked off in Shanghai. The 2025 AI Person of the Year awards were unveiled at the ceremony, showcasing the latest practices, fruitful achievements, and broad prospects of China's artificial intelligence sector.
Qiming Venture Partners portfolio company Zhipu AI CEO Zhang Peng, StepFun founder and CEO Daxin Jiang, and Infinigence AI co-founder and CEO Lixue Xia were named 2025 AI Persons of the Year.
Zhipu AI CEO Zhang Peng
StepFun Founder and CEO Daxin Jiang
Infinigence AI Co-founder and CEO Lixue Xia
Named
2025 AI Persons of the Year
- 2025 AI Person of the Year
This award targets the younger generation of AI strivers and is selected by a recommendation committee of over 100 authoritative experts including academicians, scientists, economists, entrepreneurs, renowned investors, and chief editors of mainstream media. At the ceremony, Qi Yuan, distinguished professor at Fudan University, dean of the Shanghai Academy of AI for Science, and founder of Light Year AI — a Qiming Venture Partners portfolio company — joined academicians and top scientists in announcing the ten 2025 AI Persons of the Year.
Source | China Media Group
Past Highlights
Qiming Headlines | 2025 WAIC "Qiming Venture Partners · Entrepreneurship and Investment Forum — Venture Capital Ignites the Resonance Cycle of AI Technology and Applications" Successfully Held Qiming Perspectives | Technology Grows Upward, Applications Take Root Downward — AI Resonance Cycle and 2025 Top 10 AI Outlooks Released Qiming Stars | 4 Qiming Venture Partners Portfolio Companies Named to World Artificial Intelligence Conference · SAIL Award TOP30 List
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Over 80 portfolio companies have become recognized unicorns or super-unicorns in their respective industries.
Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), GenScript ProBio (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.